We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Clene Inc
14 own
8 watching
Current Price
$0.35
$0.01
(1.91%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
53.13M
52-Week High
1.09000
52-Week Low
0.25000
Average Volume
0.37M
Dividend Yield
--
P/E Ratio
--
Market Capitalization53.13M52-Week High1.0900052-Week Low0.25000Average Volume0.37MDividend Yield--P/E Ratio--What does the Clene Inc do?
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain s energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
Read More
How much money does Clene Inc make?
News & Events about Clene Inc.
Globe Newswire
10 months ago
Peer-reviewed publication includes data from the CNM-Au8 Phase 2 RESCUE-ALS trial and its open-label-extension, up to 120 weeks of patient follow-up SALT LAKE CITY, June 26, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, Clene) and its wholly owned subsidiary Clene ...
Globe Newswire
10 months ago
Investment led byVivo Capitalwith participation fromSymBiosis,Acuta Capital Partners,AIGH Capital,Serrado Capital LLC,and other new biotech investors, with support from existing insiders$40 millionunderwritten public offering with up to an additionalpotential $130.8 millionin proceeds through future...
Globe Newswire
10 months ago
SALT LAKE CITY, June 16, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN), along with its subsidiaries Clene and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced ...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Clene Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Clene Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR...
Globe Newswire
1 year ago
SALT LAKE CITY, March 16, 2023 (GLOBE NEWSWIRE) -- Clene, Inc. (Nasdaq: CLNN) along with its subsidiaries Clene and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced ...
Frequently Asked Questions
Frequently Asked Questions
What is Clene Inc share price today?
Can Indians buy Clene Inc shares?
How can I buy Clene Inc shares from India?
Can Fractional shares of Clene Inc be purchased?
What are the documents required to start investing in Clene Inc stocks?
What is today’s traded volume of Clene Inc?
What is today’s market capitalisation of Clene Inc?
What is the 52-Week High and Low Range of Clene Inc?
What percentage is Clene Inc down from its 52-Week High?
What percentage is Clene Inc up from its 52-Week Low?
Current Price
$0.35
$0.01
(1.91%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.